Verifying…
Home / Drug A–Z / BD Micro Fine Plus Pen Needle

BD Micro Fine Plus Pen Needle

NAFDAC Reg. No. 03-6058 · Drug

Registered with NAFDAC. Registration activeAs of 27 October 2026 · synced automatically from official sources.
Product
BD Micro Fine Plus Pen Needle
NAFDAC number
03-6058
Active ingredient
Pen Needles
Strength
NA
Form
NA
Pack size
1 x 100 x 30 g x 8 mm,1 x 100 x 31 g x 5 mm,1 x 100 x 32 g x 4 mm
Manufacturer
Not listed
Applicant (holder)
Savante Consulting Limited
Approved
29 Jul 2023
Status
Active View on NAFDAC ↗
Registration valid to
26 Jul 2028
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • BD Micro Fine Plus Pen Needle is on the NAFDAC register with an active registration (03-6058). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What BD Micro Fine Plus Pen Needle is used for

From the official U.S. FDA label for BD Micro Fine Plus Pen Needle, the active ingredient registered with NAFDAC.

What it is used for

RETIN-A MICRO ® is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. RETIN-A MICRO is a retinoid indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. ( 1)

Possible side effects

Most common adverse reactions were skin irritation, skin burning, erythema, peeling, dryness, itching, and dermatitis. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Bausch Health US, LLC at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. …

Do not use if

None. None. ( 4 )

Warnings

• Local Skin Irritation : RETIN-A MICRO can cause local skin irritation, including excessive dryness, redness, swelling, peeling, itching, blistering, burning, or stinging ( 5.1 ) • Avoid use on eczematous skin or during weather extremes, such as severe wind or cold. • To reduce the risk of local skin irritation, wash the treated skin gently, using a mild, non-medicated soap, avoid washing the treated skin too often or scrubbing it hard when washing, and apply a topical moisturizer. • If severe local skin irritation occurs, discontinue use temporarily or permanently. …

Pregnancy & breastfeeding

8.1 Pregnancy Risk Summary Available data from published prospective observational studies and retrospective cohort studies over decades of use of topical tretinoin in pregnant women have not established a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data) . …

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

NAFDAC recall & alert notices

Public Alert 003/2022 – Alert on Recall of Clobetasol Propionate Ointment USP, 5%, 60g Tubes by Taro Pharmaceuticals Incorporation U.S.A, Due to Microbial Contamination10 Feb 2022 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC)  has received information from US FDA that Taro Pharmaceuticals U.S.A., Inc. is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes, to the consumer level due to the presence of Ralstonia picket…Public Alert No: 001/2022 – Efficient Laboratories, Inc. Expands Voluntary Nationwide Recall to Consumers to Include Twelve Additional Lots of Rompe Pecho CF, Rompe Pecho EX, Rompe Pecho MAX, and Rompe Pecho DM Sold in 2019 Due to Microbial Contamination Concerns26 Jan 2022 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by U.S Food and drug Administration (FDA) that Efficient Laboratories Miami, Florida. is expanding its voluntary recall to consumers to include twelve lots of Rompe Pecho CF, Rompe Pecho EX, Rompe Pecho MAX, and Rompe Pecho DM…Public Alert No: 0039/2018 – Homeopathic Aqeous Based Medicines By Eight And Company D/B/A Sprayolog Recall-Due To Microbial Contamination.17 Dec 2018 · nafdac.gov.ngThe National Agency for Food and Drug Administration and Control has been informed that Eight and Company LLC, d/b/a Sprayology USA is voluntarily recalling all lots within expiry from 10/18 to 7/22 of its aqueous-based homeopathic product line for human use. All products manufactured by the contract manufacturer, King…

Compare the brands and batch numbers in these notices with your pack, or enter your batch number above.

Check your pack of BD Micro Fine Plus Pen Needle

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About BD Micro Fine Plus Pen Needle

What is in BD Micro Fine Plus Pen Needle?

BD Micro Fine Plus Pen Needle contains Pen Needles (NA), as na, according to its NAFDAC registration record.

Is BD Micro Fine Plus Pen Needle registered with NAFDAC?

Yes. BD Micro Fine Plus Pen Needle is listed on the NAFDAC register under registration number 03-6058, and its registration is active as of 27 October 2026.

Has BD Micro Fine Plus Pen Needle been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches BD Micro Fine Plus Pen Needle in our automatically synced alert list.

How can I check that my pack of BD Micro Fine Plus Pen Needle is genuine?

Run a free authenticity scan with the NAFDAC number 03-6058, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is BD Micro Fine Plus Pen Needle used for?

RETIN-A MICRO ® is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. RETIN-A MICRO is a retinoid indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. ( 1) (Summarised from the official U.S. FDA label for BD Micro Fine Plus Pen Needle. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used BD Micro Fine Plus Pen Needle? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.